Steffen Sammet to Time Factors
This is a "connection" page, showing publications Steffen Sammet has written about Time Factors.
Connection Strength
0.024
-
Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer. J Clin Oncol. 2010 May 10; 28(14):2323-30.
Score: 0.012
-
Predicting control of primary tumor and survival by DCE MRI during early therapy in cervical cancer. Invest Radiol. 2009 Jun; 44(6):343-50.
Score: 0.012